Time evolution of cytokine profiles associated with mortality in COVID-19 hospitalized patients.

Frontiers in immunology(2022)

引用 5|浏览8
暂无评分
摘要
Hypercytokinemia is a hallmark of COVID-19 but relevant differences between survivors and non-survivors can be early observed. Combinatorial analysis of serum cytokines and chemokines can contribute to mortality risk assessment and optimize therapeutic strategies. Three clusters of cytokines have been identified as independent markers or risk factors of COVID mortality.
更多
查看译文
关键词
COVID-19,cytokines,hospitalized patients,mortality,principal component analysis - PCA
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要